Correction to ‘Integrating transcriptomics and proteomics to assess antisense oligonucleotide safety and efficacy: a time-resolved approach’

Key Points

• The objective is to address corrections in the assessment of antisense oligonucleotide safety and efficacy using transcriptomics and proteomics.
• Correcting previous findings related to transcriptomics and proteomics methods for antisense oligonucleotide assessment.
• Clarification provided regarding the original study's findings and conclusions.